ArticleAnalytical chemistry2026
Analyses of Individual Singly Charged Ions Using a High-Field Orbitrap Analyzer.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Orbitrap-based charge detection mass spectrometry (CDMS) enables the mass analysis of biomolecules at the individual-ion level. Recording longer transients boosts resolution and sensitivity for CDMS measurements. However, singly charged analytes (∼1-2 kDa) remained elusive to Orbitrap-based CDMS due to their low signal-to-noise ratios (S/N). To overcome this limitation, we implemented CDMS on a high-field Orbitrap mass analyzer (HF-OT, Exploris 480 mass spectrometer) coupled to an external data acquisition system. The HF-OT analyzer should theoretically improve the resolution by 1.7-fold and the S/N by 1.4-fold compared to a standard Orbitrap analyzer (S-OT, UHMR mass spectrometer). We first adapted an Exploris 480 mass spectrometer to allow robust detection across an extended
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.